The Hulot Laboratory seeks to identify novel predictors of response/toxicity to drugs thus allowing for a greater degree of personalized medicine than is currently available. Read More
Engineered Cardiac Tissue Developed to Study the Human Heart
February 2, 2014 - Researchers show their human engineered cardiac tissue may provide a reliable surrogate for human myocardium to improve preclinical therapeutic testing.
Long-Lasting Gene Therapy Benefits Advanced Heart Failure Patients
November 19, 2013 - Cardiovascular Research Center at Mount Sinai report promising long-term follow-up results for its single dose AAV1/SERCA2a gene therapy in advanced heart failure patients.
Blake A. Adair
Icahn School of Medicine
Cardiovascular Research Center
One Gustave L. Levy Place, Box 1030
New York, NY 10029